The efficacy of denosumab treatment for hypercalcemia in a patient with primary hyperoxaluria type 1

被引：0
|
作者：
Rozhinskaya, Liudmila [1 ]
Gronskaia, Sofia [1 ]
Grebennikova, Tatiana [1 ]
Belaya, Zhanna [1 ]
机构：
[1] Natl Med Res Ctr Endocrinol, Moscow, Russia
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-216
引用
收藏
页码：116 / 116
页数：1
相关论文
共 50 条
  • [31] Primary hyperoxaluria type 1 in Japan
    Arata Ichiyama
    Toshiaki Oda
    Eiko Maeda-Nakai
    Cell Biochemistry and Biophysics, 2000, 32 : 171 - 176
  • [32] Concomitant Treatment With Lumasiran and Nedosiran in a Child With Primary Hyperoxaluria Type 1
    Braekman, Eline
    Raes, Ann
    De Bruyne, Ruth
    Verloo, Patrick
    Prytula, Agnieszka
    KIDNEY INTERNATIONAL REPORTS, 2025, 10 (02): : 620 - 621
  • [33] Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1
    Hoppe, B.
    Beck, B.
    Gatter, N.
    von Unruh, G.
    Tischer, A.
    Hesse, A.
    Laube, N.
    Kaul, P.
    Sidhu, H.
    KIDNEY INTERNATIONAL, 2006, 70 (07) : 1305 - 1311
  • [34] Treatment options in primary hyperoxaluria Type I
    Cellini, Barbara
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (04): : 309 - 319
  • [35] TREATMENT OF TYPE-I PRIMARY HYPEROXALURIA
    GERSHOFF, SN
    NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (15): : 959 - 959
  • [36] Lumasiran: expanding the treatment options for patients with primary hyperoxaluria type 1
    Hulton, Sally-Anne
    EXPERT OPINION ON ORPHAN DRUGS, 2021, 9 (7-10): : 189 - 198
  • [37] Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment
    Cochat, Pierre
    Hulton, Sally-Anne
    Acquaviva, Cecile
    Danpure, Christopher J.
    Daudon, Michel
    De Marchi, Mario
    Fargue, Sonia
    Groothoff, Jaap
    Harambat, Jerome
    Hoppe, Bernd
    Jamieson, Neville V.
    Kemper, Markus J.
    Mandrile, Giorgia
    Marangella, Martino
    Picca, Stefano
    Rumsby, Gill
    Salido, Eduardo
    Straub, Michael
    van Woerden, Christiaan S.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (05) : 1729 - 1736
  • [38] European and American approval for new treatment for Primary Hyperoxaluria Type 1
    不详
    BJU INTERNATIONAL, 2021, 127 (04) : 401 - 401
  • [39] Molecular etiology of primary hyperoxaluria type 1: New directions for treatment
    Danpure, CJ
    AMERICAN JOURNAL OF NEPHROLOGY, 2005, 25 (03) : 303 - 310
  • [40] Restrictive cardiomyopathy in a patient with primary hyperoxaluria type II
    Matthias R. Schulze
    Rolf Wachter
    Alexander Schmeißer
    Rainer Fischer
    Ruth H. Strasser
    Clinical Research in Cardiology, 2006, 95 : 235 - 240
12345